Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (471-480 of 531) with videos related to

Pageof 54
Sort By:
Diagnostic Microbiology and Infectious Disease|October 13, 2017
Genomic characterization of an extensively drug-resistant KPC-2-producing Klebsiella pneumoniae ST855 (CC258) only susceptible to ceftazidime-avibactam isolated in BrazilCaio Augusto Martins Aires, Michael J Rybak, Juwon Yim, et al.
Journal of Pediatric Psychology|October 9, 2018
Validity, Reliability, and Measurement Invariance of the Diabetes Stress Questionnaire-Short FormKimberly L Klages, Rachel L Ankney, Kristoffer S Berlin, et al.
Infection Control and Hospital Epidemiology|August 11, 2011
Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureusKayoko Hayakawa, Dror Marchaim, Celine Vidaillac, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis<i>/oralis</i> in an <i>Ex Vivo</i> Simulated Endocarditis Vegetation ModelRazieh Kebriaei, Seth A Rice, Kyle C Stamper, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial StewardshipShigehiko Karino, Keith S Kaye, Bhagyashri Navalkele, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2019
Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure InfectionsT D Trinh, S C J Jorgensen, E J Zasowski, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsKimberly C Claeys, Evan J Zasowski, Anthony M Casapao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2020
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Antimicrobial Agents and Chemotherapy|March 8, 2017
Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective EndocarditisC Garcia-de-la-Maria, Y Q Xiong, J M Pericas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2011
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summaryCatherine Liu, Arnold Bayer, Sara E Cosgrove, et al.
Pageof 54

Showing results (471-480 of 531) with videos related to

Sort By:
Pageof 54
Diagnostic Microbiology and Infectious Disease|October 13, 2017
Genomic characterization of an extensively drug-resistant KPC-2-producing Klebsiella pneumoniae ST855 (CC258) only susceptible to ceftazidime-avibactam isolated in BrazilCaio Augusto Martins Aires, Michael J Rybak, Juwon Yim, et al.
Journal of Pediatric Psychology|October 9, 2018
Validity, Reliability, and Measurement Invariance of the Diabetes Stress Questionnaire-Short FormKimberly L Klages, Rachel L Ankney, Kristoffer S Berlin, et al.
Infection Control and Hospital Epidemiology|August 11, 2011
Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureusKayoko Hayakawa, Dror Marchaim, Celine Vidaillac, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis<i>/oralis</i> in an <i>Ex Vivo</i> Simulated Endocarditis Vegetation ModelRazieh Kebriaei, Seth A Rice, Kyle C Stamper, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial StewardshipShigehiko Karino, Keith S Kaye, Bhagyashri Navalkele, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2019
Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure InfectionsT D Trinh, S C J Jorgensen, E J Zasowski, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsKimberly C Claeys, Evan J Zasowski, Anthony M Casapao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2020
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Antimicrobial Agents and Chemotherapy|March 8, 2017
Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective EndocarditisC Garcia-de-la-Maria, Y Q Xiong, J M Pericas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2011
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summaryCatherine Liu, Arnold Bayer, Sara E Cosgrove, et al.
Pageof 54